Related Experiment Videos
INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results
F Gueyffier1, F Boutitie, J P Boissel
1Service de Pharmacologie Clinique, Lyon, France.
Insights
This study on hypertension treatment identifies patient responders using individual patient data meta-analysis. The INDANA project aims to personalize hypertension therapy by distinguishing who benefits most from antihypertensive drugs.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Antihypertensive drug treatment effects are documented, but patient benefit varies significantly with baseline cardiovascular risk.
- A small proportion of patients benefit from current hypertension treatments, prompting proposals to target high-risk individuals.
- Justifying the limitation of treatment to high-risk patients requires validating several underlying assumptions.
Purpose of the Study:
- To identify patient responders and non-responders to antihypertensive drug treatment through a comprehensive meta-analysis.
- To validate assumptions underlying the proposed strategy of targeting high-risk patients for hypertension treatment.
- To contribute to the individualization of hypertension treatment by selecting appropriate responders.
Main Methods:
- The INDANA project utilizes a meta-analysis of individual patient data (IPD) to investigate treatment response.
- The study addresses technical challenges associated with IPD meta-analysis for hypertension research.
- Data collection for the INDANA project has been successfully concluded, confirming project feasibility.
Main Results:
- The INDANA project is feasible, with data collection completed.
- Main analysis results are anticipated for 1996.
- Findings are expected to aid in selecting responders for hypertension treatment.
Conclusions:
- The INDANA project provides a robust method for analyzing individual patient data in hypertension research.
- The study's findings will support the personalized selection of patients for antihypertensive drug therapy.
- This approach aims to optimize treatment outcomes by identifying individuals most likely to respond to hypertension medications.
Abstract:
The overall effect of antihypertensive drug treatment has been well documented. The proportion of patients who benefit varies according to their baseline cardiovascular risk, and is small for the majority of people treated. Some investigators propose limiting the treatment target population to patients at high cardiovascular risk, but several assumptions must be made to justify this procedure. The INDANA project is a meta-analysis based on individual patient data, and thus offers the opportunity to check the validity of these assumptions. Its main objective is to identify responders (and non-responders) in the drug treatment of hypertension. The rationale and methods for such an approach are presented here, with the solution for some technical problems. The conclusion of the data collection has shown that the project is feasible. The results of the main analysis should be available in 1996, and should contribute to the selection of responders and to the individualization of the treatment of hypertension.